Nexeon is a bioelectronics company that has established a proven, disruptive model for identifying, funding, managing, and accelerating game-changing ideas into profitable, clinical innovations. Chief amongst Company assets is a number of patents relating to a micro-perforated balloon catheter system for use in the treatment of restenosis associated with hemodialysis. Initially, the Company will focus on driving development and commercialization of the aforementioned medical device. Nexeon also has ownership interest in various programs developing active implantable medical devices and the Internet of Things (IoT) technology systems that support the remote management of these devices.